'Other' targets in lung cancer
25 Jul 2016
'Other' targets in lung cancer
The steady progress of targeted therapies
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Polycomb repressors and epigenetic therapy
DNA repair and mutations as targets for personalised therapy
Connections in cancer-host immune signalling
Targeting and imaging invasion and metastasis
Regulation of T cells in tissues and tumours
Deciphering RAS/MAPK signalling in cancer
Changing landscape of multiple myeloma care: Expert discussion
Serum miRNAs as diagnostic tools in GI malignancies